Volume 76, Number 11, March 15, 2011
About this course
- Released: 03/14/2011
- Expires: 03/15/2013
Learning Objectives:
Upon completion of the article by Benarroch et al, the participant should be able to:
• Recognize that recurrent syncope can be a manifestation of a dopamine-secreting glomus tumor.
• State the approximate percentage of glomus tumors that are vagal paragangliomas.
• Discuss the effects of activation of the various dopamine receptors.
• State what treatment was effective in reducing syncope in this patient, and the likely mechanism of this effectiveness.
Core Competencies:
The article by Benarroch et al covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Uccelli et al, the participant should be able to:
• Recognize the risk of serious primary varicella zoster (VZ) infections associated with fingolimod therapy.
• Discuss the recommendations discussed in this report regarding VZ infection or vaccination status before starting fingolimod.
• Discuss the treatment recommendations from this study for patients who develop VZ infection during fingolimod therapy.
Core Competencies:
The article by Uccelli et al covers the following core competency:
• Medical Knowledge
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
